Filana Therapeutics Inc. (FLNA)
FLNA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7434
-3.39% on the day
Market cap
$35.9M
Nano cap
Revenue
No annual revenue filed since the period ending 2013-12-31
Net income
No annual revenue filed since the period ending 2013-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | FLNA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001069530 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2013-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2025-12-05 |
| Latest annual report FORM 10-K | 10-K | 2026-03-12 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-07-29 |
| Latest current report FORM 8-K | 8-K | 2026-09-22 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IXHL | Incannex Healthcare Inc. | $2.91 | +0.34% | $36.5M |
| LITS | Lite Strategy Inc. | $1.21 | -0.82% | $36.8M |
| NSRX | Nasus Pharma Ltd. | $3.16 | -4.82% | $37.0M |
| VERU | Veru Inc. | $2.19 | -8.94% | $37.3M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| EDSA | Edesa Biotech Inc. Common Shares | $2.85 | -3.23% | $38.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier